Cardiac hypertrophy: Stressing out the heart

Journal of Clinical Investigation

Volumn 116, Issue 6, 2006, Pages 1467-1470

  Tardiff, Jil C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; CELL FUNCTION; CHRONICITY; HEART DISEASE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STIMULUS RESPONSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; CARDIOMEGALY; DISEASE MODELS, ANIMAL; HEART; MICE; PHYSICAL CONDITIONING, ANIMAL; RATS; RECEPTORS, ADRENERGIC, BETA; STRESS;

EID: 33745222340     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28884     Document Type: Review

References (19)

1. Meerson, F.Z. 1962. Compensatory hyperfunction of the heart and cardiac insufficiency. Circ. Res. 10:250-258.
2. Lorell, B.H., Apstein, C.S., Weinberg, E.O., and Cunningham, M.J. 1990. Diastolic function in left ventricular hypertrophy: clinical and experimental relationships. Eur. Heart J. 11(Suppl. G):54-64.
3. Ho, K.K., Pinsky, J.L., Kannel, W.B., and Levy, D. 1993. The epidemiology of heart failure: the Framingham Study. J. Am. Coll. Cardiol. 22:6A-13A.
4. Raskoff, W.J., Goldman, S., and Cohn, K. 1976. The "athletic heart". Prevalence and physiological significance of left ventricular enlargement in distance runners. JAMA. 236:158-162.
5. Bevegard, B.S., and Shepherd, J.T. 1967. Regulation of the circulation during exercise in man. Physiol. Rev. 47:178-213.
6. Giusti, R., Bersohn, M.M., Malhotra, A., and Scheuer, J. 1978. Cardiac function and actomyosin ATPase activity in hearts of conditioned and deconditioned rats. J. Appl. Physiol. 44:171-174.
7. Wilkins, B.J., et al. 2004. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94:110-118.
8. Barki-Harrington, L., Perrino, C., and Rockman, H.A. 2004. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc. Res. 63:391-402.
9. Perrino, C., et al. 2006. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J. Clin. Invest. 116:1547-1560. doi:10.1172/JCI25397.
10. Shioi, T., et al. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Embo J. 19:2537-2548.
11. Frey, N., et al. 2004. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. med. 10:1336-1343.
12. Ertz-Berger, B.R., et al. 2005. Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 102:18219-18224.
13. Dorn, G.W., 2nd, and Force, T. 2005. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115:527-537. doi:10.1172/JCI200524178.
14. Nienaber, J.J., et al. 2003. Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure. J. Clin. Invest. 112:1067-1079. doi:10.1172/ JCI200318213.
15. Naga Prasad, S.V., Esposito, G., Mao, L., Koch, W.J., and Rockman, H.A. 2000. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J. biol. Chem. 275:4693-4698.
16. Crackower, M.A., et al. 2002. Regulation of myocardial contractility and cell size by distinct PI3KPTEN signaling pathways. Cell. 110:737-749.
17. Mann, D.L. 2005. Left ventricular size and shape: determinants of mechanical signal transduction pathways. Heart Fail. Rev. 10:95-100.
18. Knoll, R., et al. 2002. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 111:943-955.
19. Devereux, R.B., et al. 2004. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 292:2350-2356.